📋 Tender Overview
Contract awarded for Medication acquisition 2025 - 2027 lot-0007, title: amikacin 500mg / 2ml (equiv. amikozit 500mg/2 ml), description: according to the specifications lot-0015, title: atropine 1mg/ml (equiv. atropine sulfate 1mg/ml), description: according to the specifications lot-0053, title: dexamethasone 8mg/2ml vials, description: according to the specifications lot-0067, title: fluconazole 150 mg x 1 tablet, description: according to the specifications lot-0074, title: haloperidol 2mg/ml, description: according to the specifications lot-0090, title: loperamide 2mg tablets, description: according to the specifications lot-0100, title: moxifloxacin 400mg/250ml, description: according to the specifications lot-0104, title: omeprazole 20 mg, description: according to the specifications lot-0107, title: pantoprazole 40 mg (equiv. controloc 40mg), description: according to the specifications lot-0117, title: silymarin 150 mg (equivalent silymarin, liverplus 150 mg), description: according to the specifications lot-0124, title: tigecycline 50mg powder for injection, description: according to the specifications lot-0126, title: vancomycin 1000mg (equiv. vancomycin powder 1000mg), description: according to the specifications lot-0128, title: voriconazole 200 mg, description: according to the specifications estimated value excluding vat: 9840.00 ron.Medication acquisition 2025 - 2027